Human Reproduction, Vol. 16, No. 9, 1854-1860,
September 2001
© 2001 European Society of Human Reproduction and Embryology
RASA, a recombinant single-chain variable fragment (scFv) antibody directed against the human sperm surface: implications for novel contraceptives
Department of Cell Biology, Center for Recombinant Gamete Contraceptive Vaccinogens, University of Virginia Health System, Charlottesville, Virginia 22908, USA
BACKGROUND: A recombinant single-chain variable fragment (scFv) antibody was engineered to a tissue-specific carbohydrate epitope located on human sperm agglutination antigen-1 (SAGA-1), a sperm glycoform of CD52. METHODS AND RESULTS: cDNAs encoding the variable regions of the S19 [IgG1
] monoclonal antibody (mAb) were identified, linked, and cloned into the pCANTAB 5E vector. The recombinant anti-sperm antibody (RASA) was expressed in E. coli HB2151 cells as a 29 kDa monomer and, remarkably, also formed multimers of ~60 and 90 kDa. RASA reacted with the endogenous SAGA-1 antigen by Western blot analysis, labelled the entire human sperm surface by indirect immunofluorescence, and aggregated human spermatozoa in a tangled (head-to-head, head-to-tail, tail-to-tail) pattern of agglutination, as was also observed with the native S19 mAb. CONCLUSIONS: These results demonstrate that active recombinant antibodies can be produced to a tissue-specific carbohydrate epitope on the human sperm surface, thereby opening opportunities for novel contraceptive agents.
Key words: agglutination/antibody engineering/contraception/recombinant antibody/single-chain Fv
1 To whom correspondence should be addressed. E-mail: jch7k{at}virginia.edu
* Dr Herr serves as an officer and member of the Board of Directors of Contra Vac, Inc.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A.S. Samuel and R.K. Naz Isolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development Hum. Reprod., June 1, 2008; 23(6): 1324 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Naz Antisperm Immunity for Contraception J Androl, March 1, 2006; 27(2): 153 - 159. [Full Text] [PDF] |
||||
![]() |
A Sreekumar, K K Acharya, H S Lalitha, S S Indi, P Bali, and P B Seshagiri Germ cell-specific localization of immunoreactive riboflavin carrier protein in the male golden hamster: appearance during spermatogenesis and role in sperm function Reproduction, May 1, 2005; 129(5): 577 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bohring and W. Krause Immune infertility: towards a better understanding of sperm (auto)-immunity: The value of proteomic analysis Hum. Reprod., May 1, 2003; 18(5): 915 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. McCauley, B. E. Kurth, E. J. Norton, K. L. Klotz, V. A. Westbrook, A. J. Rao, J. C. Herr, and A. B. Diekman Analysis of a Human Sperm CD52 Glycoform in Primates: Identification of an Animal Model for Immunocontraceptive Vaccine Development Biol Reprod, June 1, 2002; 66(6): 1681 - 1688. [Abstract] [Full Text] [PDF] |
||||



